Jentadueto XR 2.5 mg/1

Jentadueto XR 2.5 mg/1 combines linagliptin and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control as part of a comprehensive treatment plan.

Jentadueto XR 2.5 mg/1 is primarily used for managing type 2 diabetes in adults. It works by improving blood sugar levels, often when diet and exercise alone are not sufficient. This medication is typically prescribed to help control high blood sugar, a common concern for those with type 2 diabetes. It is not intended for treating type 1 diabetes or diabetic ketoacidosis.

Common effects of Jentadueto XR 2.5 mg/1 may include gastrointestinal discomfort, such as diarrhea or nausea. Some users might experience headache or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Jentadueto XR 2.5 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow the prescribed dosage and administration instructions. Regular monitoring of blood sugar levels is recommended while using this medication.

Jentadueto XR 2.5 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.